These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35619019)

  • 1. LncRNA VPS9D1-AS1 Sponging miR-520a-5p Contributes to the Development of Uterine Corpus Endometrial Carcinoma by Enhancing BIRC5 Expression.
    Chen L; Shen M
    Mol Biotechnol; 2022 Dec; 64(12):1328-1339. PubMed ID: 35619019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA VPS9D1-AS1 enhances proliferation, invasion, and epithelial-mesenchymal transition in endometrial cancer via miR-377-3p/SGK1.
    Peng TF; Zhou YJ; Zhou J; Zhou Y; Li XC; Ouyang Q
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1048-1059. PubMed ID: 36245426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis.
    Ren W; Ouyang L
    Environ Toxicol; 2024 Sep; 39(9):4447-4458. PubMed ID: 38953363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA VPS9D1-AS1 regulates miR-187-3p/fibroblast growth factor receptor-like 1 axis to promote proliferation, migration, and invasion of prostate cancer cells.
    Wu C; Chen J; Wang D
    Chin J Physiol; 2023; 66(5):295-305. PubMed ID: 37929340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GATA3-AS1 promoted invasion and migration in human endometrial carcinoma by regulating the miR-361/ARRB2 axis.
    Liu YX; Yuan S; Liu XJ; Huang YX; Qiu P; Gao J; Deng GP
    J Mol Med (Berl); 2022 Sep; 100(9):1271-1286. PubMed ID: 35788718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-ZNF252P-AS1/miR-15b-5p promotes the proliferation of keloid fibroblast by regulating the BTF3-STAT3 signaling pathway.
    Guo Y; Li M; Long J; Fan P; Zuo C; Wang Y
    J Dermatol Sci; 2022 Dec; 108(3):146-156. PubMed ID: 36641250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPS9D1-AS1, a novel long-non-coding RNA, acts as a tumor promoter by regulating the miR-324-5p/ITGA2 axis in colon adenocarcinoma.
    Huang G; Yang Y; Lv M; Huang T; Zhan X; Kang W; Hou J
    Am J Transl Res; 2022; 14(2):955-966. PubMed ID: 35273698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
    Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
    Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA
    Han X; Huang T; Han J
    Aging (Albany NY); 2020 Jan; 12(1):370-386. PubMed ID: 31902794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p.
    Wang Y; Zou Y; Zhang Q; Chen D; Lin L
    J Healthc Eng; 2022; 2022():2223149. PubMed ID: 35444785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis.
    Liu X; Song J; Kang Y; Wang Y; Chen A
    J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
    Suo ST; Gong P; Peng XJ; Niu D; Guo YT
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ST8SIA6-AS1 facilitates hepatocellular carcinoma progression by governing miR-651-5p/TM4SF4 axis.
    Mou Y; Ding X
    Anticancer Drugs; 2022 Sep; 33(8):741-751. PubMed ID: 35946523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D.
    Wang X; Chen Q; Wang X; Li W; Yu G; Zhu Z; Zhang W
    Biomed Pharmacother; 2020 Feb; 122():109557. PubMed ID: 31918265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.